Status:

COMPLETED

Open Versus Laparoscopic Dismembered Pyeloplasty Among Adult Patients With Primary Pelvi-Ureteric Junction Obstruction

Lead Sponsor:

Tanta University

Conditions:

Open

Laparoscopic

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To prospectively compare the perioperative, morphological and functional outcomes on short and medium term between laparoscopic (LP) and open pyeloplasty (OP) patients.

Detailed Description

Pelvi-ureteric junction obstruction (PUJO) is defined as a functionally significant impairment of the flow of urine from the kidney's renal pelvis into the proximal ureter. Open pyeloplasty (OP) has ...

Eligibility Criteria

Inclusion

  • All adult patients (above 18 years old) with primary pelvi-ureteric junction obstruction indicated for active intervention as
  • Symptoms such as recurrent flank pain, recurrent urinary tract infection and rarely hypertension.
  • Breakthrough urinary tract infections while on prophylactic antibiotics.
  • Increasing renal antero-posterior diameter, or decreasing renal parenchymal thickness by ultrasound.
  • Low or decreasing differential renal function, but above 10%.

Exclusion

  • Patients having poor ipsilateral renal function \< 10%.
  • Patients with previous pelvi-ureteric junction obstruction repair.
  • Associated renal stones.
  • Patients unfit for surgery according to American Society of Anesthesiologists classification.
  • Contraindications for laparoscopy as (marked obesity, large ventral hernias, gross coagulopathy, abdominal wall sepsis, vertebral deformities…).
  • Pediatric patients.
  • Pregnant women.
  • Vesicoureteral reflux.
  • Congenital renal anomalies as (horse- shoe kidney, pelvic kidney, mal- rotated kidney ...).
  • Single functioning kidney.
  • Malignancy.
  • Refusal of written consent.

Key Trial Info

Start Date :

October 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2023

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT06572371

Start Date

October 1 2022

End Date

October 1 2023

Last Update

August 27 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tanta University

Tanta, ElGharbia, Egypt, 31527